Evolent Health (EVH) Tops Q1 EPS by 2c, Revenue Beats, Offers Q2 Guidance

Evolent Health (NYSE: EVH) reported Q1 EPS of ($0.31), $0.02 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $198.4 million versus the consensus estimate of $192.7 million.

GUIDANCE:

Evolent Health sees Q2 2019 revenue of $187-195 million, versus the consensus of $193.9 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Piper Sandler Reiterates Overweight Rating on Evolent Health (EVH)
• Wintrust Financial (WTFC) Tops Q1 EPS by 49c
• Alcoa (AA) Misses Q1 EPS by 19c